Carl Zeiss Meditec (ETR:AFX) has been given a €48.00 ($57.14) price target by equities research analysts at Deutsche Bank in a note issued to investors on Thursday. The brokerage currently has a “neutral” rating on the stock. Deutsche Bank’s price target would indicate a potential downside of 7.71% from the stock’s previous close.
A number of other analysts have also issued reports on the company. Nord/LB set a €60.00 ($71.43) price target on Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Tuesday. Independent Research set a €54.00 ($64.29) price target on Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, December 8th. Commerzbank set a €42.00 ($50.00) price target on Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, December 8th. Berenberg Bank set a €48.00 ($57.14) price target on Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Friday, December 8th. Finally, set a €52.00 ($61.90) price target on Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Friday, November 10th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. Carl Zeiss Meditec currently has an average rating of “Hold” and an average target price of €50.36 ($59.95).
Shares of Carl Zeiss Meditec (AFX) opened at €52.01 ($61.92) on Thursday. Carl Zeiss Meditec has a 12-month low of €32.14 ($38.26) and a 12-month high of €53.35 ($63.51).
ILLEGAL ACTIVITY WARNING: This story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://www.dispatchtribunal.com/2017/12/16/carl-zeiss-meditec-afx-pt-set-at-48-00-by-deutsche-bank.html.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.